Cite
MLA Citation
Josep M Llibre et al.. “Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.” Lancet, vol. 391, no. 10123, 2018, pp. 839–849. http://access.bl.uk/ark:/81055/vdc_100057442708.0x000055